Svenska
|
Site map
|
Contact
Home
Company
Products and Pipeline
Partners and distributors
Investors
Press
Contact
Investors
Annual reports
Financial reports
The stock
Investment presentations
Press releases
Financial calendar
Shareholders
Analysts
Corporate governance
CEO interview
Investors
/
Analysts
Analysts who continuously monitor Moberg Pharma:
Peter Östling, Redeye
Phone: +46 8 545 013 39
E-mail:
peter.ostling@redeye.se
Klas Palin, Redeye
Phone: +46 8 545 013 44
E-mail:
klas.palin@redeye.se
Patrik Långström, Remium
Phone: +46 8 454 32 42
E-mail:
patrick.langstrom@remium.com
Contact Investor relations:
Magnus Persson, IR
Phone: +46 733 55 26 01
Email:
magnus.persson@mobergpharma.se
Peter Wolpert, CEO
Phone +46 8 522 307 00
Email:
peter.wolpert@mobergpharma.se
Moberg Pharma AB (publ)
Gustavslundsvägen 42, 5 tr, SE-167 51 Bromma, Sweden
Phone: +46 8 522 30 700
info@mobergpharma.se
site policy
© Moberg Pharma AB 2013